| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |